Hitekno.com – A Education recently showed that targeting specific cell types that are ‘important in tumor development’ could help treat cell carcinoma kidneyand that drug able to do so is readily available.
Reported by Sputnik Newsa new hope has appeared for suffering people kidney cancer known as renal cell carcinoma, as researchers in the UK have pointed to an existing drug they say could help patients with the disease.
Read also:
– Blibli holds a big payday, provides 5 million items to attract customers
– JKT 48 fan’s husband gets angry at his wife for this, netizen: Oshi is number one, wife jumps first
– On sale today, here are the four pluses of the Redmi Pad
A team from the University of Cambridge’s Wellcome Sanger Institute and Cambridge University Hospitals NHS Foundation Trust have speculated that a type of white blood cell known as a macrophage, some of which contain the IL1B gene, is ‘critical in tumor development’.
The authors of this new study, which was published in Cancer cellargue that targeting these IL1B macrophages could help treat renal cell carcinoma, and that existing drugs originally designed to prevent lung cancer could be used for it.
“I’m optimistic that targeting IL1B macrophages could give us a way to treat renal cell carcinoma without having to have surgery,” said Dr. Thomas Mitchell, senior author of the new study, was quoted in a press release from Cambridge University Hospitals NHS Foundation Trust.
While the researchers have yet to prove their hypothesis through clinical trials, they are already exploring this new option.
